Esteban Eduardo Díaz González

Esteban Eduardo Díaz González

Auto-generated profile, based on publicly available information

Esteban Eduardo Díaz González

Universidad Autónoma de Nuevo León, México

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 July 2016 in The Journal of Infectious Diseases
Verified
Journal Article
Open access
PDF file
MGMathilde Guerbois
Mathilde Guerbois
IFIldefonso Fernandez-Salas
Ildefonso Fernandez-Salas
SASasha R. Azar
Sasha R. Azar
RDRogelio Danis-Lozano
Rogelio Danis-Lozano
CACelia M. Alpuche-Aranda
Celia M. Alpuche-Aranda
SWScott Weaver
Scott Weaver
Background. After decades of obscurity, Zika virus (ZIKV) has spread through the Americas since 2015 accompanied by congenital microcephaly and Guillain-Barré syndrome. Although these epidemics presumably involve transmission by Aedes aegypti, no direct evidence of vector involvement has been reported, prompting speculation that other mosquitoes such as Culex quinquefasciatus could be involved. Methods. We detected an outbreak of ZIKV infection in southern Mexico in late 2015. Sera from suspected ZIKV-infected patients were analyzed for viral RNA and antibodies. Mosquitoes were collected in and around patient homes and tested for ZIKV. Results. Of 119 suspected ZIKV-infected patients, 25 (21%) were confirmed by RT-PCR of serum collected 1–8 days after the onset of signs and symptoms including rash, arthralgia, headache, pruritus, myalgia, and fever. Of 796 mosquitoes collected, A. aegypti yielded ZIKV detection by RT-PCR in 15 of 55 pools (27.3%). No ZIKV was detected in C. quinquefasciatus. ZIKV sequences derived from sera and mosquitoes showed a monophyletic relationship suggestive of a point source introduction from Guatemala. Conclusions. These results demonstrate the continued, rapid northward progression of ZIKV into North America with typically mild disease manifestations, and implicate A. aegypti for the first time as a principal vector in North America.

1 December 2015 in Antiviral Research
Verified
Journal Article
Closed access
IFIldefonso Fernández-Salas
Ildefonso Fernández-Salas
RDRogelio Danis-Lozano
Rogelio Danis-Lozano
MCMauricio Casas-Martínez
Mauricio Casas-Martínez
AUArmando Ulloa
Armando Ulloa
JBJ. Guillermo Bond
J. Guillermo Bond
EDEsteban E. Díaz-González
Esteban E. Díaz-González

9 December 2015 in The American Journal of Tropical Medicine and Hygiene
Verified
Journal Article
Closed access
EDEsteban E. Díaz-González
Esteban E. Díaz-González
TKTiffany F. Kautz
Tiffany F. Kautz
ADAlicia Dorantes-Delgado
Alicia Dorantes-Delgado
IMIliana R. Malo-García
Iliana R. Malo-García
MLMaricela Laguna-Aguilar
Maricela Laguna-Aguilar
IFIldefonso Fernández-Salas
Ildefonso Fernández-Salas
During a chikungunya fever outbreak in late 2014 in Chiapas, Mexico, entomovirological surveillance was performed to incriminate the vector(s). In neighborhoods, 75 households with suspected cases were sampled for mosquitoes, of which 80% (60) harbored Aedes aegypti and 2.7% (2) Aedes albopictus. A total of 1,170 Ae. aegypti and three Ae. albopictus was collected and 81 pools were generated. Although none of the Ae. albopictus pools were chikungunya virus (CHIKV)–positive, 18 Ae. aegypti pools (22.8%) contained CHIKV, yielding an infection rate of 32.3/1,000 mosquitoes. A lack of herd immunity in conjunction with high mosquito populations, poor vector control services in this region, and targeted collections in locations of human cases may explain the high infection rate in this vector. Consistent with predictions from experimental studies, Ae. aegypti appears to be the principal vector of CHIKV in southern Mexico, while the role of Ae. albopictus remains unknown.

1 November 2015 in Emerging Infectious Diseases
Verified
Journal Article
Open access
TKTiffany F. Kautz
Tiffany F. Kautz
EDEsteban E. Díaz-González
Esteban E. Díaz-González
JEJesse H. Erasmus
Jesse H. Erasmus
IMIliana R. Malo-García
Iliana R. Malo-García
RLRose M. Langsjoen
Rose M. Langsjoen
IFIldefonso Fernández-Salas
Ildefonso Fernández-Salas
Since chikungunya virus (CHIKV) was introduced into the Americas in 2013, its geographic distribution has rapidly expanded. Of 119 serum samples collected in 2014 from febrile patients in southern Mexico, 79% were positive for CHIKV or IgM against CHIKV. Sequencing results confirmed CHIKV strains closely related to Caribbean isolates.

13 August 2015 in Tropical Medicine & International Health
Verified
Journal Article
Closed access
PDF file
NJNele Janssen
Nele Janssen
IFIldefonso Fernandez‐Salas
Ildefonso Fernandez‐Salas
EGEsteban Eduardo Díaz González
Esteban Eduardo Díaz González
AGAlejandro Gaytan‐Burns
Alejandro Gaytan‐Burns
CGCarlos E. Medina‐De la Garza
Carlos E. Medina‐De la Garza
HJHanna Jöst
Hanna Jöst

24 October 2017 in PLOS ONE
Verified
Journal Article
Open access
PDF file
RDRogelio Danis-Lozano
Rogelio Danis-Lozano
EDEsteban Eduardo Díaz-González
Esteban Eduardo Díaz-González
KTKarina Del Carmen Trujillo-Murillo
Karina Del Carmen Trujillo-Murillo
SCSandra Caballero-Sosa
Sandra Caballero-Sosa
JSJesús Sepúlveda-Delgado
Jesús Sepúlveda-Delgado
IFIldefonso Fernández-Salas
Ildefonso Fernández-Salas
The emerging chikungunya virus (CHIKV), is an arbovirus causing intense outbreaks in North America. The situation in Mexico is alarming, and CHIKV threatens to spread further throughout North America. Clinical and biological features of CHIKF outbreaks in Mexico have not been well described; thus, we conducted a cross sectional study of a CHIKV outbreak in Chiapas, Southern Mexico to further characterize these features. We collected blood samples from patients suspected of having chikungunya fever (CHIKF) who presented to Clinical Hospital ISSSTE Dr. Roberto Nettel in Tapachula, Chiapas, Mexico. In addition to the clinical examination, real-time polymerase chain reaction (PCR) standardized for the Asian Chikungunya lineage and/or enzyme-linked immunosorbent assay for immunoglobulin M (IgM) were used to confirm CHIKV diagnosis. Of a total of 850 patients who presented with probably CHIKV at Hospital “Dr. Roberto Nettel”, 112 probable CHIKF cases were enrolled in this study from November 2014- June 2015, of which 95 patients (84.8%) were CHIKV positive and 17 were negative (15.2%). Of these 95 CHIKV positive patients, 62 were positive by real-time reverse transcriptase PCR (+qRT-PCR); and 33 were seropositive to +IgM with a negative qRT-PCR. The most frequent symptoms reported were fever (100%), headache (82.3%), polyarthralgia (72.1%), and exanthem (82.3%). Biological abnormalities observed during CHIKV infection were lymphopenia (41.1%), leukopenia (51.6%), elevated transaminases (30.5%-46.3%) and high LDH (46.3%) and CRP (60.0%). Clinical and biological data obtained from this study is providing more useful information for benchmarking purposes with outbreaks from different parts of the world and would be helpful for better patient care and treatment.